NYU Langone Health: Mental Health Benefits From One Dose of Psychedelic Drug Last for Years in People With Cancer
January 29, 2020
January 29, 2020
NEW YORK, Jan. 29 -- NYU Langone Health, an academic medical center affiliated with New York University, issued the following news release:
Following up on their landmark 2016 study, researchers at NYU Grossman School of Medicine found that a one-time, single-dose treatment of psilocybin, a compound found in psychedelic mushrooms, combined with psychotherapy, appears to be associated with significant improvements in emotional and existential distress in people with cancer. These eff . . .
Following up on their landmark 2016 study, researchers at NYU Grossman School of Medicine found that a one-time, single-dose treatment of psilocybin, a compound found in psychedelic mushrooms, combined with psychotherapy, appears to be associated with significant improvements in emotional and existential distress in people with cancer. These eff . . .